Aptevo Therapeutics Inc. (APVO) NASDAQ

5.13

+2.31(+81.91%)

Updated at June 18 04:00PM

Currency In USD

Valuation

Market Cap23.8M
Enterprise Value19.72M
P/E Ratio-0.32
PEG Ratio-0.05
Price/Sales Ratio0
Price/Book Ratio-5.08
Enterprise/Revenue0
Enterprise/EBITDA-0.25

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-2.84
Return On Equity-7.79

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-23.78M
Net Income-24.13M
Diluted EPS-84.67

Balance Sheet

Total Cash2.14M
Total Cash/Share1.47
Total Debt4.42M
Total Debt/Equity-3
Current Ratio0.67
Book Value Per Share-1.01

Price History

52-Week Change-98.72
52-Week High485.44
52-Week Low2.81
Moving Average 50 Days9.19
Moving Average 200 Days96.09

Statistics

Average Volume2.26M
Shares Outstanding700,000
% Held by Institutions15.37

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMay 27, 2025